Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Biden to convene virtual virus summit on fringe of UN

Published 09/17/2021, 04:54 PM
Updated 09/17/2021, 04:57 PM
© Reuters. U.S. President Joe Biden clears his throat as he delivers remarks on the economy during a speech in the East Room of the White House in Washington, U.S., September 16, 2021. REUTERS/Leah Millis

By Steve Holland

WASHINGTON (Reuters) -U.S. President Joe Biden will convene a virtual COVID-19 summit on Wednesday on the margins of the U.N. General Assembly aimed at boosting vaccinations worldwide with the goal of ending the pandemic by the end of 2022.

White House spokeswoman Jen Psaki said the United States will be asking participants to commit to "a higher level of ambition" on making vaccines available on a more equitable basis and getting shots in arms, among other steps recommended to address the pandemic.

Biden travels to New York on Monday for his first trip as president to attend the U.N. General Assembly and will speak to the gathered world leaders on Tuesday. He will convene the virus summit from the White House.

A senior administration official said Biden will issue a call to action. The summit is not a pledging conference, "though we hope and expect some partners will come prepared to announce new efforts."

"We need to end the pandemic – as soon as possible, aiming by the end of next year. We also need to build capacity so that all countries, everywhere, are able to prevent, detect, and respond to future biological threats and mitigate outbreaks on their communities," the official said.

Biden wants to attack the pandemic globally by bringing together global leaders from the private sector, non-governmental organizations, philanthropists and civil society leaders to help end the pandemic and prevent the next one, the official said.

More talks on the subject are expected among world leaders, including at the G20 summit to be held in Rome at the end of October.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

More than 227.26 million people have been reported to be infected by the novel coronavirus globally and 4,877,603​ have died, according to a Reuters tally https://www.reuters.com/business/healthcare-pharmaceuticals/worldwide-coronavirus-cases-cross-15903-million-death-toll-3444309-2021-05-11.

Infections have been reported in more than 210 countries and territories since the first cases were identified in China in December 2019.

Latest comments

welcome to the pharmaceutical industrial complex
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.